Displaying 3251 - 3300 of 5176 results
Released Company Title Industry Topic
06 Nov 2024
17:00 CET
CAMBI ASA Cambi ASA: Third-quarter results 2024 50202030 Electronic Equipment: Pollution Control Additional regulated information required to be disclosed under the laws of a Member State
06 Nov 2024
17:00 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics Announces Updates on its Inverse Vaccine Platform at PEGS Europe 20103010 Biotechnology Non-regulatory press releases
06 Nov 2024
16:58 CET
SAGA PURE Disclosure of large shareholding and mandatory notification of trade 50206030 Marine Transportation Mandatory notification of trade primary insiders
06 Nov 2024
16:48 CET
PHOTOCURE Photocure ASA: Invitation to presentation of third quarter 2024 financial results 20103015 Pharmaceuticals Non-regulatory press releases
06 Nov 2024
16:39 CET
ERAMET Eramet : Informations relatives au nombre total de droits de vote et d’actions au 31 octobre 2024 55102050 Nonferrous Metals Other subject
06 Nov 2024
16:38 CET
CREDIT AGRICOLE CREDIT AGRICOLE SA : DECLARATION DES DROITS DE VOTE OCTOBRE 2024 30101010 Banks Other subject
06 Nov 2024
16:30 CET
AKVA GROUP AKVA group ASA: Extension of incentive plan 50204000 Machinery: Industrial Mandatory notification of trade primary insiders
06 Nov 2024
16:23 CET
SpareBank 1 Østfold Akershus SpareBank 1 Østfold Akershus: Meldepliktig handel tilbakekjøp 30101010 Banks Utsteders meldeplikt ved handel i egne aksjer
06 Nov 2024
16:14 CET
PERNOD RICARD Pernod Ricard : déclaration des droits de vote - octobre 2024 45101015 Distillers and Vintners Other subject
06 Nov 2024
16:12 CET
ATEA Atea Share Savings Program - notification of trade 10101010 Computer Services Meldepliktig handel for primærinnsidere
06 Nov 2024
16:11 CET
EIFFAGE Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social 50101010 Construction Other subject
06 Nov 2024
16:04 CET
VIRBAC Virbac : Déclaration d'actions et de droits de vote 10/2024 20103015 Pharmaceuticals Corporate life
06 Nov 2024
16:04 CET
VIRBAC Virbac : Declaration of the number of shares and voting rights 10/2024 20103015 Pharmaceuticals Corporate life
06 Nov 2024
15:55 CET
Nordea Eiendomskreditt AS Euronext Oslo Børs – Nordea Eiendomskreditt AS - Received application for listing of bonds - Additional regulated information required to be disclosed under the laws of a Member State
06 Nov 2024
15:55 CET
Nordea Eiendomskreditt AS Euronext Oslo Børs – Nordea Eiendomskreditt AS - Mottatt søknad om notering av obligasjonslån - Annen informasjonspliktig regulatorisk informasjon
06 Nov 2024
15:35 CET
BlueNord ASA Major Holding Notification form BLUENORD ASA 60101010 Oil: Crude Producers Major shareholding notifications
06 Nov 2024
15:20 CET
ACCSYS TECHNOLOGIES PLC Accsys Technologies PLC: Notice of Interim Results and Presentation 50101035 Building Materials: Other Other subject
06 Nov 2024
15:20 CET
Rogaland Sparebank Boligkredit Finansiell kalender - Annen informasjonspliktig regulatorisk informasjon
06 Nov 2024
15:13 CET
Sparebanken Sør Boligkreditt Sparebanken Sør Boligkreditt AS: Repurchase of own debt - Additional regulated information required to be disclosed under the laws of a Member State
06 Nov 2024
15:13 CET
Sparebanken Sør Boligkreditt Sparebanken Sør Boligkreditt AS: Tilbakekjøp av obligasjonsgjeld - Annen informasjonspliktig regulatorisk informasjon
06 Nov 2024
15:03 CET
SpareBank 1 Østfold Akershus SpareBank 1 Østfold Akershus: Mulig erverv av egne egenkapitalbevis 30101010 Banks Utsteders meldeplikt ved handel i egne aksjer
06 Nov 2024
15:00 CET
MERCIALYS Mercialys: Number of Outstanding Shares and Voting Rights as of October 31, 2024 35102045 Retail REITs Other subject
06 Nov 2024
15:00 CET
ICADE MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES 35102030 Office REITs Other subject
06 Nov 2024
15:00 CET
MERCIALYS Mercialys : Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 31 octobre 2024 35102045 Retail REITs Other subject
06 Nov 2024
15:00 CET
ICADE INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D\'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL 35102030 Office REITs Other subject
06 Nov 2024
14:55 CET
BELFIUS3.625%PL Project Mona Lisa - Tender Results Announcement - Other subject
06 Nov 2024
14:44 CET
SFL Corporation Ltd. SFL - Third Quarter 2024 Results Presentation - Additional regulated information required to be disclosed under the laws of a Member State
06 Nov 2024
14:36 CET
OBOS-banken AS OBOS-banken AS: Tilbakekjøp av egne obligasjoner (OBOBA26) - Annen informasjonspliktig regulatorisk informasjon
06 Nov 2024
14:33 CET
OBOS-banken AS OBOS-banken AS: Tap of green senior preferred NOK FRN bond - Endringer i rettighetene til aksjer / verdipapirer
06 Nov 2024
14:05 CET
ECIT AS B-AKSJER ECIT har entered into an agreement to acquire shares in KPMG Bokad ehf. 50205020 Professional Business Support Services Non-regulatory press releases
06 Nov 2024
14:02 CET
- Floatel International: Q3 2024 interim report and audiocast on November 26, 2024 - Non-regulatory press releases
06 Nov 2024
13:52 CET
NAVAMEDIC Navamedic ASA: Mandatory notice of trade 20103015 Pharmaceuticals Mandatory notification of trade primary insiders
06 Nov 2024
13:42 CET
Kraft Bank ASA Finansiell kalender 30101010 Banks Annen informasjonspliktig regulatorisk informasjon
06 Nov 2024
13:42 CET
MEDINCELL S.A. Medincell: 25% Raise in 2024 UZEDY® Revenue Outlook & Key Milestone Reached for Olanzapine LAI clinical Phase 3 20103010 Biotechnology New
06 Nov 2024
13:42 CET
MEDINCELL S.A. Medincell : prévision de revenus 2024 relevée de 25% pour UZEDY® et franchissement d’une étape majeure dans l’essai clinique de phase 3 de l'Olanzapine LAI 20103010 Biotechnology New
06 Nov 2024
13:34 CET
LYTIX BIOPHARMA AS Lovende fase II-studie i pasienter med tidligfase føflekkreft startet opp ved Radiumhospitalet - første pasient behandlet med Lytix’ kreftbehandling 20103010 Biotechnology Ikke-informasjonspliktige pressemeldinger
06 Nov 2024
13:34 CET
LYTIX BIOPHARMA AS First patient treated in new phase II clinical trial at Radiumhospitalet in Oslo – promising use of Lytix cancer treatment in patients with early-stage melanoma 20103010 Biotechnology Non-regulatory press releases
06 Nov 2024
13:34 CET
MR BRICOLAGE Evolution mensuelle du 31 octobre 2024 40401025 Home Improvement Retailers Other subject
06 Nov 2024
13:27 CET
Fertiberia Corpora 24/28 FRN EUR FLOOR C Ny rente - Renteregulering
06 Nov 2024
13:27 CET
Sandefjord komm 24/26 FRN Ny rente - Renteregulering
06 Nov 2024
13:00 CET
BEACONSMIND AG beaconsmind Group Expands Healthcare Sector and Gains Renafan as a New Customer 10101020 Consumer Digital Services Other subject
06 Nov 2024
12:58 CET
Vegfinans Innlandet AS Rentefastsettelse - Renteregulering
06 Nov 2024
12:58 CET
Larvik Kommune Rentefastsettelse - Renteregulering
06 Nov 2024
12:58 CET
Nortura Konsernpensjonskasse Interest Adjustment - Renteregulering
06 Nov 2024
12:58 CET
Trøndelag Sparebank Rentefastsettelse - Renteregulering
06 Nov 2024
12:58 CET
SPAREBANK 1 HELGELAND Rentefastsettelse 30101010 Banks Renteregulering
06 Nov 2024
12:57 CET
Nidaros Sparebank Rentefastsettelse 30101010 Banks Renteregulering
06 Nov 2024
12:57 CET
SpareBank 1 Nord-Norge Rentefastsettelse 30101010 Banks Renteregulering
06 Nov 2024
12:57 CET
SpareBank 1 Nord-Norge Rentefastsettelse 30101010 Banks Renteregulering
06 Nov 2024
12:57 CET
Eidsberg Sparebank Rentefastsettelse - Renteregulering